These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

207 related items for PubMed ID: 12792856

  • 1. High mobility group box-1 as a therapeutic target downstream of tumor necrosis factor.
    Czura CJ, Yang H, Tracey KJ.
    J Infect Dis; 2003 Jun 15; 187 Suppl 2():S391-6. PubMed ID: 12792856
    [Abstract] [Full Text] [Related]

  • 2. High mobility group box 1 protein as a late-acting mediator of acute lung inflammation.
    Lutz W, Stetkiewicz J.
    Int J Occup Med Environ Health; 2004 Jun 15; 17(2):245-54. PubMed ID: 15387080
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. HMGB1 as a DNA-binding cytokine.
    Andersson U, Erlandsson-Harris H, Yang H, Tracey KJ.
    J Leukoc Biol; 2002 Dec 15; 72(6):1084-91. PubMed ID: 12488489
    [Abstract] [Full Text] [Related]

  • 5. HMGB1 as a cytokine and therapeutic target.
    Yang H, Wang H, Czura CJ, Tracey KJ.
    J Endotoxin Res; 2002 Dec 15; 8(6):469-72. PubMed ID: 12697092
    [Abstract] [Full Text] [Related]

  • 6. The gesture life of high mobility group box 1.
    Friedman SG, Czura CJ, Tracey KJ.
    Curr Opin Clin Nutr Metab Care; 2003 May 15; 6(3):283-7. PubMed ID: 12690260
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Activation of human umbilical vein endothelial cells leads to relocation and release of high-mobility group box chromosomal protein 1.
    Mullins GE, Sunden-Cullberg J, Johansson AS, Rouhiainen A, Erlandsson-Harris H, Yang H, Tracey KJ, Rauvala H, Palmblad J, Andersson J, Treutiger CJ.
    Scand J Immunol; 2004 Dec 15; 60(6):566-73. PubMed ID: 15584967
    [Abstract] [Full Text] [Related]

  • 9. Mini-review: The nuclear protein HMGB1 as a proinflammatory mediator.
    Erlandsson Harris H, Andersson U.
    Eur J Immunol; 2004 Jun 15; 34(6):1503-12. PubMed ID: 15162419
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Endogenous HMGB1 is required in endotoxin tolerance.
    Li S, Luo C, Yin C, Peng C, Han R, Zhou J, He Q, Zhou J.
    J Surg Res; 2013 Nov 15; 185(1):319-28. PubMed ID: 23866790
    [Abstract] [Full Text] [Related]

  • 13. High-mobility group box 1 (HMGB1) protein: friend and foe.
    Ulloa L, Messmer D.
    Cytokine Growth Factor Rev; 2006 Jun 15; 17(3):189-201. PubMed ID: 16513409
    [Abstract] [Full Text] [Related]

  • 14. [Effects of escharectomy during shock stage on tissue high mobility group box-1 expression and balance of pro-/anti-inflammatory response in rats after severe thermal injury].
    Wang ZT, Yao YM, Sheng ZY, Yu Y, Yang HM, Wang Q, Liu Q, Qiao L, Zhou G.
    Zhonghua Wai Ke Za Zhi; 2004 Jul 22; 42(14):839-44. PubMed ID: 15363270
    [Abstract] [Full Text] [Related]

  • 15. Transcutaneous vagus nerve stimulation reduces serum high mobility group box 1 levels and improves survival in murine sepsis.
    Huston JM, Gallowitsch-Puerta M, Ochani M, Ochani K, Yuan R, Rosas-Ballina M, Ashok M, Goldstein RS, Chavan S, Pavlov VA, Metz CN, Yang H, Czura CJ, Wang H, Tracey KJ.
    Crit Care Med; 2007 Dec 22; 35(12):2762-8. PubMed ID: 17901837
    [Abstract] [Full Text] [Related]

  • 16. HMGB1, a potent proinflammatory cytokine in sepsis.
    Huang W, Tang Y, Li L.
    Cytokine; 2010 Aug 22; 51(2):119-26. PubMed ID: 20347329
    [Abstract] [Full Text] [Related]

  • 17. High mobility group box 1 in the pathogenesis of inflammatory and autoimmune diseases.
    Voll RE, Urbonaviciute V, Herrmann M, Kalden JR.
    Isr Med Assoc J; 2008 Jan 22; 10(1):26-8. PubMed ID: 18300566
    [Abstract] [Full Text] [Related]

  • 18. Systemic and local high mobility group box 1 concentrations during severe infection.
    van Zoelen MA, Laterre PF, van Veen SQ, van Till JW, Wittebole X, Bresser P, Tanck MW, Dugernier T, Ishizaka A, Boermeester MA, van der Poll T.
    Crit Care Med; 2007 Dec 22; 35(12):2799-804. PubMed ID: 17901841
    [Abstract] [Full Text] [Related]

  • 19. HMGB1 as a mediator of necrosis-induced inflammation and a therapeutic target in arthritis.
    Andersson U, Tracey KJ.
    Rheum Dis Clin North Am; 2004 Aug 22; 30(3):627-37, xi. PubMed ID: 15261345
    [Abstract] [Full Text] [Related]

  • 20. Systemic involvement of high-mobility group box 1 protein and therapeutic effect of anti-high-mobility group box 1 protein antibody in a rat model of crush injury.
    Shimazaki J, Matsumoto N, Ogura H, Muroya T, Kuwagata Y, Nakagawa J, Yamakawa K, Hosotsubo H, Imamura Y, Shimazu T.
    Shock; 2012 Jun 22; 37(6):634-8. PubMed ID: 22392147
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 11.